Metraipolis › archive › dc_08d1cfd8f09b

Neurofilament light chain (NfL) as a surrogate outcome measure for GM2 gangliosidoses — Europe PMC PMID:42467089

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42467089
DOI
10.1007/s00415-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-10-18T04:28:17.656Z
SHA-256 of the archived text
b239fdca34cdbe95ef29a975d8965f68eb1fb5bcb4762a7bc2ab7909414d5bd6
Stable URL of this page
https://metraipolis.com/documento/dc_08d1cfd8f09b

How to cite

Neurofilament light chain (NfL) as a surrogate outcome measure for GM2 gangliosidoses — Europe PMC PMID:42467089 — Europe PMC (en), https://europepmc.org/article/MED/42467089 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_08d1cfd8f09b (Metraipolis archive dc_08d1cfd8f09b, sha256 b239fdca34cdbe95ef29a975d8965f68eb1fb5bcb4762a7bc2ab7909414d5bd6)
BibTeX
@misc{dc08d1cfd8f09b,
  title = {Neurofilament light chain (NfL) as a surrogate outcome measure for GM2 gangliosidoses — Europe PMC PMID:42467089},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42467089},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_08d1cfd8f09b; sha256 b239fdca34cdbe95ef29a975d8965f68eb1fb5bcb4762a7bc2ab7909414d5bd6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42467089. Agents can read the archived copy with the MCP tool read_document.